Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention

Published:2023-07 Issue: Volume:199 Page:7-17
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Greco Antonio^ORCID,Scilletta Sabrina,Faro Denise Cristiana,Agnello Federica,Mauro Maria Sara,Laudani Claudio,Occhipinti Giovanni,Spagnolo Marco,Rochira Carla,Finocchiaro Simone,Mazzone Placido Maria,Ammirabile Nicola,Landolina Davide,Imbesi Antonino,Capodanno Davide

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. ESC Scientific Document Group.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice [published correction appears in Eur Heart J 2022;43:4468];Visseren;Eur Heart J,2021

2. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes;Knuuti;Eur Heart J,2020

3. Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation;Hylek;Stroke,2006

4. The changing landscape of randomized clinical trials in cardiovascular disease;Jones;J Am Coll Cardiol,2016

5. Dual antiplatelet or dual antithrombotic therapy for secondary prevention in high-risk patients with stable coronary artery disease?;Sumaya;Thromb Haemost,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke;Expert Opinion on Pharmacotherapy;2024-07-02

2. Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI;JACC: Cardiovascular Interventions;2024-06

3. Future of factor XI inhibitors in cardiovascular practice;Minerva Cardiology and Angiology;2024-05

4. Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management;Journal of Clinical Medicine;2024-02-22

5. Periprocedural myocardial infarction and injury;European Heart Journal: Acute Cardiovascular Care;2024-02-07